Abiopharma

TIPTREE INC. (TIPT) Reports the reporting period Financial Results TIPTREE INC. (TIPT) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 390
• Net Income: 14246
• EPS: 0.34
• Cash and equivalents: 33401
  • anticipated in these forward-looking statements as a result of various factors, including, but not limited to those described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K, and as described in the Company’s other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date of this release. The factors described therein are not necessarily all of the important factors that could cause actual results or developments to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors also could affect our forward-looking statements. Consequently, our actual performance could be materially different from the results described or anticipated by our forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by the federal securities laws, we undertake no obligation to update any forward-looking statements. Page 2 Tiptree Inc. Condensed Consolidated Balance Sheets (Unaudited)($ in thousands, except share data) As of March 31, 2026